6,412 Shares in National Health Investors, Inc. (NHI) Purchased by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale acquired a new stake in shares of National Health Investors, Inc. (NYSE:NHI) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 6,412 shares of the real estate investment trust’s stock, valued at approximately $434,000.

Several other hedge funds have also modified their holdings of NHI. BlackRock Inc. grew its position in shares of National Health Investors by 5.1% during the 4th quarter. BlackRock Inc. now owns 3,807,739 shares of the real estate investment trust’s stock valued at $287,028,000 after acquiring an additional 183,350 shares during the period. Allianz Asset Management GmbH boosted its holdings in National Health Investors by 34.4% in the 4th quarter. Allianz Asset Management GmbH now owns 530,800 shares of the real estate investment trust’s stock worth $40,012,000 after buying an additional 136,000 shares during the period. Renaissance Technologies LLC boosted its holdings in National Health Investors by 30.4% in the 4th quarter. Renaissance Technologies LLC now owns 471,700 shares of the real estate investment trust’s stock worth $35,557,000 after buying an additional 110,000 shares during the period. Amundi Pioneer Asset Management Inc. bought a new position in National Health Investors in the 4th quarter worth $2,308,000. Finally, Guggenheim Capital LLC boosted its holdings in National Health Investors by 80.0% in the 4th quarter. Guggenheim Capital LLC now owns 52,333 shares of the real estate investment trust’s stock worth $3,945,000 after buying an additional 23,252 shares during the period. 70.02% of the stock is owned by hedge funds and other institutional investors.

Several research analysts recently weighed in on the stock. Capital One raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating in a report on Friday, May 11th. SunTrust Banks set a $75.00 target price on shares of National Health Investors and gave the stock a “hold” rating in a report on Monday, January 22nd. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $75.00 target price on shares of National Health Investors in a report on Tuesday, May 8th. ValuEngine downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. Finally, KeyCorp dropped their target price on shares of National Health Investors from $70.00 to $60.00 and set a “sell” rating for the company in a report on Tuesday, April 17th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $73.56.

In related news, CEO D. Eric Mendelsohn purchased 2,000 shares of the firm’s stock in a transaction on Thursday, February 22nd. The shares were acquired at an average price of $65.47 per share, for a total transaction of $130,940.00. Following the purchase, the chief executive officer now directly owns 10,580 shares in the company, valued at $692,672.60. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP John L. Spaid purchased 500 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was bought at an average price of $64.95 per share, for a total transaction of $32,475.00. Following the purchase, the vice president now owns 971 shares in the company, valued at $63,066.45. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 2,812 shares of company stock worth $183,910. Corporate insiders own 5.63% of the company’s stock.

Shares of NHI stock opened at $70.04 on Tuesday. The firm has a market capitalization of $2.87 billion, a price-to-earnings ratio of 13.14, a P/E/G ratio of 3.59 and a beta of 0.42. National Health Investors, Inc. has a 52 week low of $62.71 and a 52 week high of $81.60. The company has a debt-to-equity ratio of 0.88, a quick ratio of 15.21 and a current ratio of 15.21.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Friday, February 16th. The real estate investment trust reported $0.90 EPS for the quarter, missing the consensus estimate of $1.33 by ($0.43). The company had revenue of $71.06 million during the quarter, compared to analysts’ expectations of $71.36 million. National Health Investors had a return on equity of 11.69% and a net margin of 53.88%. equities analysts expect that National Health Investors, Inc. will post 5.5 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 10th. Shareholders of record on Friday, June 29th will be paid a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 5.71%. The ex-dividend date is Thursday, June 28th. National Health Investors’s payout ratio is currently 75.05%.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply